Therapeutically Targeting Tumor Microenvironment–mediated Drug Resistance in Estrogen Receptor–positive Breast Cancer

Journal of Experimental Medicine - United States
doi 10.1084/jem.20171818
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer

Scientific Reports
Multidisciplinary
2020English

Local Estrogen Axis in the Human Bone Microenvironment Regulates Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2017English

Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2018English

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2017English

TOP2A RNA Expression and Recurrence in Estrogen Receptor-Positive Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

[11C]Choline Positron Emission Tomography in Estrogen Receptor-Positive Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Targeting Proteasome-Associated Deubiquitinases as a Novel Strategy for the Treatment of Estrogen Receptor-Positive Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2018English

The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy